Skip to Content
Merck
  • High levels of antibodies to Plasmodium falciparum liver stage antigen-1 in naturally infected individuals in Myanmar.

High levels of antibodies to Plasmodium falciparum liver stage antigen-1 in naturally infected individuals in Myanmar.

The Korean journal of parasitology (2008-10-03)
Hyeong-Woo Lee, Sung-Ung Moon, Yeon-Joo Kim, Shin-Hyeong Cho, Khin Lin, Byoung-Kuk Na, Tong-Soo Kim
ABSTRACT

Plasmodium falciparum liver stage antigen-1 (PfLSA-1) is one of the few antigens expressed exclusively in liver stage parasites. In this study, we evaluated the antibody responses against recombinant PfLSA-1 in naturally infected individuals in Myanmar. High levels of antibody responses (70.7%) were detected in 82 serum samples from 116 infected individuals, and IgG responses to PfLSA-1 principally composed of responses of IgG1 and IgG3 subclasses. These results show that PfLSA-1 elicits effective antibody responses in individuals infected with P. falciparum, and thus it could be not only an attractive candidate protein for vaccine development, but also a useful antigen for serodiagnosis of the infection.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Monoclonal Anti-Human IgG1 antibody produced in mouse, clone 8c/6-39, ascites fluid
Sigma-Aldrich
Monoclonal Anti-Human IgG4 antibody produced in mouse, clone HP-6025, ascites fluid
Sigma-Aldrich
Monoclonal Anti-Human IgG2 (Fc specific) antibody produced in mouse, clone HP-6002, ascites fluid
Sigma-Aldrich
Monoclonal Anti-Human IgG3 antibody produced in mouse, clone HP-6050, ascites fluid